Dr. Stefan Walzer

The AI for Pharma Market Access Course

With Dr Stefan Walzer

Course Details

THE CONTENT

AI is revolutionising the pharma market access process, driving unprecedented levels of productivity, efficiency, and impact. The extent to which AI will enhance your role and career depends on how effectively and strategically you apply it.

This two-day course is your fast track to mastering the current use of the most powerful AI tools in market access. You will gain practical insights and expert advice on applying AI effectively and confidently in your market access role. The course focuses on real-world applications, enabling you to learn, collaborate, experiment, and grow in this rapidly evolving field.
 

The course was a real eye-opener. AI tools will continue to support our industry, helping to bring innovative drugs and devices to the patients who need them.

Roche

Laurent Cohen, Access Engagement Manager - Belgium - April 2025


THE EXPERT

Dr Stefan Walzer is a recognised leader in applying AI to healthcare market access.

  • As the founder and CEO of MArS Market Access & Pricing Strategy GmbH, he initiated the use of AI platforms and tools to revolutionise dossier preparation, payer negotiations, and strategic decision-making. 

  • His career includes pivotal roles such as Global Payer Strategy Leader at F. Hoffmann – La Roche AG

  • He is the author of of over 40 peer-reviewed articles and more than 400 abstracts.

  • He is also a well-regarded lecturer in market access, pricing, and negotiation, with teaching experience at top universities in Germany. 

  • He holds a PhD in Health Economics from the University of Zurich and qualifications from the University of Tübingen and the London School of Hygiene & Tropical Medicine.

 

THE AUDIENCE & INTERACTIVE LEARNING FORMAT

If you work in a pharma or medtech market access team, this course is designed for you.

Whether you are new to AI or looking to deepen your practical understanding, you will benefit from:

  • Hands-on practice during group work on a business case that runs throughout the course

  • Interactive exercises and real-world applications of AI in market access

  • Expert feedback tailored to your specific challenges and questions

  • Peer learning from international colleagues facing similar industry challenges

  • Deep-dive discussions and collaborative problem-solving

This format creates a practical and supportive environment for you to confidently explore and apply AI-driven solutions in your daily work!

  1. Master the essentials of AI in pharma market access: Understand key terminology, explore the transformative impact of AI, and tackle industry-specific challenges.

  2. Integrate AI-driven tools with confidence: Learn how to seamlessly incorporate AI into market access processes to boost efficiency and achieve superior outcomes.

  3. Discover the best AI systems for your needs: Get an overview of available AI technologies, along with their pros and cons, tailored to pharma market access applications.

  4. Gain hands-on experience with AI in action: Participate in practical exercises using AI-driven tools for market access planning, systematic literature reviews, dossier writing, and payer negotiations.
    (Features a real-life prostate cancer case study to simulate and solve real-world challenges across the market access lifecycle.)

  5. Learn from your peers in pharma market access: Benefit from peer insights as they will share their challenges, experiences, and innovative solutions.

Course agenda

 

 

 

Day 1
10:00Welcome & Introductions
10:30Understanding AI and How it is Transforming Pharma Market Access
 
  • Defining different types of AI: Machine Learning, Neural Networks, Generative AI (GenAI) and Large Language Models (LLMs)
  • Where is AI already used within (big) Pharma? Who are fast adopters?
  • What do HTA agencies recommend in terms of AI use?
  • What are the key market access activities in a pharma product’s lifecycle where AI can play a role?
11:00Coping With Ethical, Legal and Regulatory Challenges 
 
  • Ethical considerations for GenAI usage in pharma market access
  • Overview of the legal and regulatory framework in Europe: AI Act, GDPR, EMA recommendations, EFPIA recommendations etc. 
11:30Coffee Break
11:45Using AI for Early Market Access Planning 
 
  • How does a typical market access plan look like and what information do I need for an early plan?
  • Can I use existing publicly available AI platforms such as ChatGPT, Gemini & Co.?
12:15Lunch Break
13:15Using AI for Early Market Access Planning - Group work on a Prostate Cancer Case 
 

Working in groups, participants will develop components of a market access plan for prostate cancer with freely available GPTs. Each group will work on one country. Group results will be presented in plenary. The expert-trainer will then share his outcome.

  • Epidemiology – key data in EU-5 and the US
  • EMA and FDA decisions in prostate cancer – what has happened in the last 5 years?
  • HTA decisions in EU-5 – which payer decisions have happened, and which endpoints and comparators were chosen by payers in EU-5 countries? Any insights you can find for the US?
14:15Using AI for Systematic Literature Research (SLR) 
 
  • Which AIs exist for SLRs and what are the differences?
14:45Coffee Break
15:00Using AI for SLR - Group Work on a Prostate Cancer Case
 

Working in groups, participants will use one of the commercially available SLR platforms. The example indication will again be prostate cancer. Group results will be presented in plenary. The expert-trainer will then share his outcome.

  • Development of PICOs for 1L prostate cancer for the US and Europe
  • Producing an SLR for prostate cancer
  • Snapshot into data extraction – a data extraction sheet will be prepared which should be developed in the SLR platform.  
16:00Using LLMs For Health Economic Models
 
  • Basics of health economic analysis and how can LLMs support
  • LLMs cannot calculate, right? But maybe they can still support in building models
16:30Wrap-up of Day 1 – Final Q&A
16:45Close Day 1
 
Day 2
09:00Recap of Day 1
09:30Using AI for Reimbursement Dossier Writing
 
  • Available AI tools to support reimbursement dossier writing – Advantages and disadvantages
  • Group work on prostate cancer case, utilising an AI platform
    Working in groups, participants will perform the following steps:
    • SLR upload into the system
    • Critical review of a specific chapter created by AI
    • Plenary discussion of pros & cons of AI-based writing 
10:30Coffee Break
10:45Using AI for National & Regional Payer Negotiations
 
  • Negotiation basics – how to prepare in the healthcare setting
  • Negotiations and objection handling with payers
  • Preparation of Q&As and individual discussions with AI 
12:00Lunch Break
13:00Using AI for Payer Negotiations - Group Work on a Prostate Cancer Case
 
  • AI in conjunction with virtual reality – next level education & preparation
  • Group work on a prostate cancer case using an AI & VR platform
    Working in groups, participants will practice the following:
    • Q&A learning – audio-in / audio-out
    • Virtual Reality application – preparation of payer discussions & negotiations
14:00What Would Be The Future of AI in Market Access?
 
  • What have we learnt?
  • Where has AI already arrived?
  • What might be the future, given the pace of AI advancements
15:15Closing Remarks
 
  • Recap of key learnings
  • Next steps and resources for further learning
15:30End of Course

 

Download Brochure

 

Complete the below form to download the full course brochure. It outlines the detailed agenda, learning outcomes, expert info and some testimonials from past participants.

 

 

UPCOMING DATES & FORMATS - FEES

23-24 September 2025

Brussels

Early bird € 2 970

(until 08/08/2025)

(Full fee € 3 370)

16-17 December 2025

Brussels

Early bird € 2 970

(until 31/10/2025)

(Full fee € 3 370)

 


TIMING & LOCATION

  • Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).

  • Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).

  • Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.

All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .

 

GROUP DISCOUNTS

Team discounts can be offered to 2 or more delegates from the same company.

Email Annelies Swaan, Director Business Operations, for more details. 

 

HOW TO REGISTER

  • Click the green “Register” button on your preferred course session.
    The registration wizard will guide you through the process.

  • Alternatively, download the offline registration form and send the completed form to Annelies Swaan.

 

PAYMENT OPTIONS

  • Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).

  • Bank Transfer: Details provided with your invoice.

For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.

 

INCLUDED IN THE REGISTRATION FEE

  • Access to a highly interactive, small-group course (max 20 participants)

  • Course materials in both digital and hard copy format

  • Certificate of attendance signed by the experts and CELforPharma

  • Opportunities for networking and informal discussions during coffee/tea breaks and lunch

  • A group dinner in a nearby restaurant on the evening of day 1

 

VAT INFORMATION

Prices exclude VAT. VAT application depends on course format and your location:

  • Face-to-Face in Belgium: 21% Belgian VAT applies

  • Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.

 

TRANSFER & CANCELLATION POLICY

Flexible Transfer

If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.

Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.

Registration Cancellation

  • Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.

  • Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.

  • More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.

If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
 

The average Recommendation Score from participants of the last session was 

9,2/10!

 

 

Testimonials from past participants:

The course was a real eye-opener. AI tools will continue to support our industry, helping to bring innovative drugs and devices to the patients who need them.

Roche

Laurent Cohen, Access Engagement Manager - Belgium - April 2025

People interested in this course are typically also interested in: 

Do you want to upskill your team?

We can organise this training in-company (face-to-face or live online) and customise it to your specific focus and needs.

Fill in the below form and Inge Cornelis, Director of Client & Product Projects, will contact you with further information.
 

Course Details

Dates & Locations

23-24 September 2025

Brussels

Register

16-17 December 2025

Brussels

Register
  • The audience for this course is restricted to a maximum of 12 delegates.

Upcoming Session

23-24 September 2025, Brussels

Early bird € 2 970

(until 08/08/2025)

 (Full fee € 3 370)

Prices are excl. VAT

THE CONTENT

AI is revolutionising the pharma market access process, driving unprecedented levels of productivity, efficiency, and impact. The extent to which AI will enhance your role and career depends on how effectively and strategically you apply it.

This two-day course is your fast track to mastering the current use of the most powerful AI tools in market access. You will gain practical insights and expert advice on applying AI effectively and confidently in your market access role. The course focuses on real-world applications, enabling you to learn, collaborate, experiment, and grow in this rapidly evolving field.
 

The course was a real eye-opener. AI tools will continue to support our industry, helping to bring innovative drugs and devices to the patients who need them.

Roche

Laurent Cohen, Access Engagement Manager - Belgium - April 2025


THE EXPERT

Dr Stefan Walzer is a recognised leader in applying AI to healthcare market access.

  • As the founder and CEO of MArS Market Access & Pricing Strategy GmbH, he initiated the use of AI platforms and tools to revolutionise dossier preparation, payer negotiations, and strategic decision-making. 

  • His career includes pivotal roles such as Global Payer Strategy Leader at F. Hoffmann – La Roche AG

  • He is the author of of over 40 peer-reviewed articles and more than 400 abstracts.

  • He is also a well-regarded lecturer in market access, pricing, and negotiation, with teaching experience at top universities in Germany. 

  • He holds a PhD in Health Economics from the University of Zurich and qualifications from the University of Tübingen and the London School of Hygiene & Tropical Medicine.

 

THE AUDIENCE & INTERACTIVE LEARNING FORMAT

If you work in a pharma or medtech market access team, this course is designed for you.

Whether you are new to AI or looking to deepen your practical understanding, you will benefit from:

  • Hands-on practice during group work on a business case that runs throughout the course

  • Interactive exercises and real-world applications of AI in market access

  • Expert feedback tailored to your specific challenges and questions

  • Peer learning from international colleagues facing similar industry challenges

  • Deep-dive discussions and collaborative problem-solving

This format creates a practical and supportive environment for you to confidently explore and apply AI-driven solutions in your daily work!

  1. Master the essentials of AI in pharma market access: Understand key terminology, explore the transformative impact of AI, and tackle industry-specific challenges.

  2. Integrate AI-driven tools with confidence: Learn how to seamlessly incorporate AI into market access processes to boost efficiency and achieve superior outcomes.

  3. Discover the best AI systems for your needs: Get an overview of available AI technologies, along with their pros and cons, tailored to pharma market access applications.

  4. Gain hands-on experience with AI in action: Participate in practical exercises using AI-driven tools for market access planning, systematic literature reviews, dossier writing, and payer negotiations.
    (Features a real-life prostate cancer case study to simulate and solve real-world challenges across the market access lifecycle.)

  5. Learn from your peers in pharma market access: Benefit from peer insights as they will share their challenges, experiences, and innovative solutions.

Course agenda

 

 

 

Day 1
10:00Welcome & Introductions
10:30Understanding AI and How it is Transforming Pharma Market Access
 
  • Defining different types of AI: Machine Learning, Neural Networks, Generative AI (GenAI) and Large Language Models (LLMs)
  • Where is AI already used within (big) Pharma? Who are fast adopters?
  • What do HTA agencies recommend in terms of AI use?
  • What are the key market access activities in a pharma product’s lifecycle where AI can play a role?
11:00Coping With Ethical, Legal and Regulatory Challenges 
 
  • Ethical considerations for GenAI usage in pharma market access
  • Overview of the legal and regulatory framework in Europe: AI Act, GDPR, EMA recommendations, EFPIA recommendations etc. 
11:30Coffee Break
11:45Using AI for Early Market Access Planning 
 
  • How does a typical market access plan look like and what information do I need for an early plan?
  • Can I use existing publicly available AI platforms such as ChatGPT, Gemini & Co.?
12:15Lunch Break
13:15Using AI for Early Market Access Planning - Group work on a Prostate Cancer Case 
 

Working in groups, participants will develop components of a market access plan for prostate cancer with freely available GPTs. Each group will work on one country. Group results will be presented in plenary. The expert-trainer will then share his outcome.

  • Epidemiology – key data in EU-5 and the US
  • EMA and FDA decisions in prostate cancer – what has happened in the last 5 years?
  • HTA decisions in EU-5 – which payer decisions have happened, and which endpoints and comparators were chosen by payers in EU-5 countries? Any insights you can find for the US?
14:15Using AI for Systematic Literature Research (SLR) 
 
  • Which AIs exist for SLRs and what are the differences?
14:45Coffee Break
15:00Using AI for SLR - Group Work on a Prostate Cancer Case
 

Working in groups, participants will use one of the commercially available SLR platforms. The example indication will again be prostate cancer. Group results will be presented in plenary. The expert-trainer will then share his outcome.

  • Development of PICOs for 1L prostate cancer for the US and Europe
  • Producing an SLR for prostate cancer
  • Snapshot into data extraction – a data extraction sheet will be prepared which should be developed in the SLR platform.  
16:00Using LLMs For Health Economic Models
 
  • Basics of health economic analysis and how can LLMs support
  • LLMs cannot calculate, right? But maybe they can still support in building models
16:30Wrap-up of Day 1 – Final Q&A
16:45Close Day 1
 
Day 2
09:00Recap of Day 1
09:30Using AI for Reimbursement Dossier Writing
 
  • Available AI tools to support reimbursement dossier writing – Advantages and disadvantages
  • Group work on prostate cancer case, utilising an AI platform
    Working in groups, participants will perform the following steps:
    • SLR upload into the system
    • Critical review of a specific chapter created by AI
    • Plenary discussion of pros & cons of AI-based writing 
10:30Coffee Break
10:45Using AI for National & Regional Payer Negotiations
 
  • Negotiation basics – how to prepare in the healthcare setting
  • Negotiations and objection handling with payers
  • Preparation of Q&As and individual discussions with AI 
12:00Lunch Break
13:00Using AI for Payer Negotiations - Group Work on a Prostate Cancer Case
 
  • AI in conjunction with virtual reality – next level education & preparation
  • Group work on a prostate cancer case using an AI & VR platform
    Working in groups, participants will practice the following:
    • Q&A learning – audio-in / audio-out
    • Virtual Reality application – preparation of payer discussions & negotiations
14:00What Would Be The Future of AI in Market Access?
 
  • What have we learnt?
  • Where has AI already arrived?
  • What might be the future, given the pace of AI advancements
15:15Closing Remarks
 
  • Recap of key learnings
  • Next steps and resources for further learning
15:30End of Course

 

Download Brochure

 

Complete the below form to download the full course brochure. It outlines the detailed agenda, learning outcomes, expert info and some testimonials from past participants.

 

 

UPCOMING DATES & FORMATS - FEES

23-24 September 2025

Brussels

Early bird € 2 970

(until 08/08/2025)

(Full fee € 3 370)

16-17 December 2025

Brussels

Early bird € 2 970

(until 31/10/2025)

(Full fee € 3 370)

 


TIMING & LOCATION

  • Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).

  • Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).

  • Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.

All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .

 

GROUP DISCOUNTS

Team discounts can be offered to 2 or more delegates from the same company.

Email Annelies Swaan, Director Business Operations, for more details. 

 

HOW TO REGISTER

  • Click the green “Register” button on your preferred course session.
    The registration wizard will guide you through the process.

  • Alternatively, download the offline registration form and send the completed form to Annelies Swaan.

 

PAYMENT OPTIONS

  • Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).

  • Bank Transfer: Details provided with your invoice.

For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.

 

INCLUDED IN THE REGISTRATION FEE

  • Access to a highly interactive, small-group course (max 20 participants)

  • Course materials in both digital and hard copy format

  • Certificate of attendance signed by the experts and CELforPharma

  • Opportunities for networking and informal discussions during coffee/tea breaks and lunch

  • A group dinner in a nearby restaurant on the evening of day 1

 

VAT INFORMATION

Prices exclude VAT. VAT application depends on course format and your location:

  • Face-to-Face in Belgium: 21% Belgian VAT applies

  • Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.

 

TRANSFER & CANCELLATION POLICY

Flexible Transfer

If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.

Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.

Registration Cancellation

  • Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.

  • Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.

  • More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.

If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
 

The average Recommendation Score from participants of the last session was 

9,2/10!

 

 

Testimonials from past participants:

The course was a real eye-opener. AI tools will continue to support our industry, helping to bring innovative drugs and devices to the patients who need them.

Roche

Laurent Cohen, Access Engagement Manager - Belgium - April 2025

Do you want to upskill your team?

We can organise this training in-company (face-to-face or live online) and customise it to your specific focus and needs.

Fill in the below form and Inge Cornelis, Director of Client & Product Projects, will contact you with further information.
 

Dates & Locations

23-24 September 2025

Brussels

Register

16-17 December 2025

Brussels

Register
  • The audience for this course is restricted to a maximum of 12 delegates.